Cite

HARVARD Citation

    Lu, L. et al. (2021). Immune‐related adverse events predict responses to PD‐1 blockade immunotherapy in hepatocellular carcinoma. International journal of cancer. 149 (4), pp. 959-966. [Online]. 
  
Back to record